Open Demat Account

Glenmark Pharmaceuticals -GLENMARK Share Price

Sector: Pharmaceuticals

₹ 1,057.20

-13.90 (-1.30%)

CMPApr 30,2024 12:00 AM

Trade in Glenmark Pharmaceuticals with IIFl Securities! Trade Now

Performance

Glenmark Pharmaceuticals LTD KEY RATIOS

sector: Pharmaceuticals

  • CMP

    -

    -
  • Open
  • ₹ 1,075.00
  • Prev. Close
  • ₹ 1,071.10
  • Turnover(Lac.)
  • ₹ 10,067
  • Day's High
  • ₹ 1,081.60
  • Day's Low
  • ₹ 1,054.50
  • 52 Week's High
  • ₹ 1,098.00
  • 52 Week's Low
  • ₹ 536.25
  • Book Value
  • ₹ 653
  • Face Value
  • ₹ 1
  • Mkt Cap (₹ Cr.)
  • 29,833
  • P/E
  • 28.32
  • EPS
  • 37.29
  • Divi. Yield
  • 0.24

Glenmark Pharmaceuticals LTD PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr. View All Peer Comparison

MORE ABOUT GLENMARK PHARMACEUTICALS LTD

Summary

Glenmark Pharmaceuticals Ltd was incorporated in November 18th, 1977. The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets. The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology, Respiratory and Dermatology. Its branded generics business has a significant presence in markets across emerging economies including India. The company has 14 manufacturing facilities across US, India, Argentina, Czech Republic and Switzerland. The generics busine Read More


Reports by Glenmark Pharmaceuticals LTD


Reports by Glenmark Pharmaceuticals LTD

x